Astrocytes: biology and pathology

Abstract

Astrocytes are specialized glial cells that outnumber neurons by over fivefold. They contiguously tile the entire central nervous system (CNS) and exert many essential complex functions in the healthy CNS. Astrocytes respond to all forms of CNS insults through a process referred to as reactive astrogliosis, which has become a pathological hallmark of CNS structural lesions. Substantial progress has been made recently in determining functions and mechanisms of reactive astrogliosis and in identifying roles of astrocytes in CNS disorders and pathologies. A vast molecular arsenal at the disposal of reactive astrocytes is being defined. Transgenic mouse models are dissecting specific aspects of reactive astrocytosis and glial scar formation in vivo. Astrocyte involvement in specific clinicopathological entities is being defined. It is now clear that reactive astrogliosis is not a simple all-or-none phenomenon but is a finely gradated continuum of changes that occur in context-dependent manners regulated by specific signaling events. These changes range from reversible alterations in gene expression and cell hypertrophy with preservation of cellular domains and tissue structure, to longlasting scar formation with rearrangement of tissue structure.Increasing evidence points towards the potential of reactive astrogliosis to play either primary or contributing roles in CNS disorders via loss of normal astrocyte functions or gain of abnormal effects. This article reviews (1) astrocyte functions in healthy CNS, (2) mechanisms and functions of reactive astrogliosis and glial scar formation, and (3) ways in which reactive astrocytes may cause or contribute to specific CNS disorders and lesions.

Metformin Improves Neurologic Outcome Via AMP‐Activated Protein Kinase–Mediated Autophagy Activation in a Rat Model of Cardiac Arrest and Resuscitation

“…Consistent with previous studies, herein, our data demonstrate that long‐term metformin pretreatment affords strong neuroprotection and can be lifesaving under the conditions of CA/CPR. Moreover, our data show that metformin pretreatment suppresses the activation of microglia and astrocytes, which may represent part of the mechanism accounting for metformin‐mediated neuroprotection in CA/CPR because microgliosis and astrocytosis are well known to contribute to delayed neuronal loss and mitochondria dysfunction in ischemic brain injuries 41, 42, 43…”

Pericyte‐derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion

“…Our results also showed that BMP4 strongly suppressed maturation of primary OPCs and converted OPCs into astrocytes in differentiation media. Compared with 1.2‐ to 2‐fold changes in angiogenesis, the degree of inducing astrogliogenesis 49 and suppressing oligodendrogenesis was exponential. Furthermore, even when the OPCs were cultured in proliferation media which should maintain an OPC state, BMP4 treatment decreased Pdgfra mRNA expression in a dose‐dependent manner.…”

Emerging findings into molecular mechanism of brain metastasis

“…SERPIN I1, encoding the plasminogen activator (PA) inhibitor neuroserpin (NS), is commonly expressed in the brain. The PA could degrade the thrombus through activating the fibrinolytic enzyme, and take part in other neuro‐matrix reactions at the same time 127. Under normal circumstances, neurons will overexpress NS to resist the adverse reactions that derived from over secretion of plasma enzymes.…”